Rood I M, Seijger C G W, van Waarde J A, de Maat M M R, Verhave J C, Blans M J
Tijdschr Psychiatr. 2017;59(1):47-51.
In the last few years, gamma hydroxybutyric acid (GHB) has been used increasingly as a party drug; this has led to a marked increase in the number of requests for professional help with the treatment of GHB addiction. Pharmaceutical GHB (sodium oxybate, the sodium-salt of GHB), registered for cataplexia in narcolepsy patients, is used off-label to treat the withdrawal symptoms associated with GHB addiction. Pharmaceutical GHB has a high sodium load. In this report we present the cases of two patients who developed symptomatic hypernatremia following treatment with pharmaceutical GHB and who thereafter needed intensive care for the severe withdrawal symptoms that they experienced.
在过去几年中,γ-羟基丁酸(GHB)越来越多地被用作聚会毒品;这导致寻求专业帮助治疗GHB成瘾的人数显著增加。用于发作性睡病患者猝倒症治疗的药用GHB(羟丁酸钠,GHB的钠盐)被用于治疗GHB成瘾相关的戒断症状,属于超适应症用药。药用GHB的钠负荷很高。在本报告中,我们介绍了两名患者的病例,他们在接受药用GHB治疗后出现了症状性高钠血症,随后因经历的严重戒断症状而需要重症监护。